目的:探索珍龙醒脑胶囊治疗脑梗死恢复早期肢体运动障碍的临床疗效和作用机制。方法:对29例脑梗死恢复早期肢体运动障碍的患者,给予4周的藏药珍龙醒脑胶囊口服治疗。治疗4周后,观察患者《中风病证候要素评价量表》、Fugl-Meyer运动功能...目的:探索珍龙醒脑胶囊治疗脑梗死恢复早期肢体运动障碍的临床疗效和作用机制。方法:对29例脑梗死恢复早期肢体运动障碍的患者,给予4周的藏药珍龙醒脑胶囊口服治疗。治疗4周后,观察患者《中风病证候要素评价量表》、Fugl-Meyer运动功能评定量表(Fugl-Meyer Assessment,FMA)和美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分的改变及不良反应发生情况,并在治疗前后对患者进行磁共振扩散张量成像,采用基于纤维束示踪的空间统计方法获取治疗前后各向异性分数值差异的脑区进行分析。结果:治疗后患者的内火、痰湿、血瘀证候的积分较治疗前降低(P<0.05);FMA总分和NIHSS总分较治疗前改善(P<0.05);胼胝体体部、胼胝体压部、胼胝体毯、丘脑后辐射、放射冠、左侧上纵束、左侧外囊、右侧内囊前肢等脑区的各向异性分数值较治疗前升高(P<0.05)。治疗期间,受试者无不良反应发生。结论:珍龙醒脑胶囊治疗脑梗死恢复早期肢体运动障碍的患者,用药4周是有效且安全的。珍龙醒脑胶囊能有效改善脑梗死恢复期患者的肢体运动功能障碍,其作用机制可能与胼胝体、放射冠等脑区受损白质纤维束的修复与重组相关。展开更多
Vertebrobasilar dolichoectasia(VBD),a rare posterior circulation vascular variant disease,is an important risk factor for many acute cerebrovascular diseases.An insufficient understanding of VBD often leads to misdiag...Vertebrobasilar dolichoectasia(VBD),a rare posterior circulation vascular variant disease,is an important risk factor for many acute cerebrovascular diseases.An insufficient understanding of VBD often leads to misdiagnose.Two cases of VBD that were initially diagnosed as posterior circulation watershed infarction are reported here.Absence of common causes of stroke including hypoperfusion,blood system diseases,carotid and aortic dissection,and eosinophil elevation,the symptoms of the 2 patients met the diagnostic criteria of VBD.Both patients displayed symptoms that were in line with the Traditional Chinese Medicine(TCM)syndrome pattern of"Qi deficiency and blood stasis".Accordingly,they were comprehensively treated with Supplementing Qi and activating blood circulation method.The clinical manifestations of the 2 patients were remarkably improved and no recurrence of watershed infarction was found in a 1-year follow-up.A detailed medical history and laboratory examination are capable of improving diagnostic accuracy of VBD.TCM treatment based on syndrome identification might be a promising candidate for VBD management.展开更多
文摘目的:探索珍龙醒脑胶囊治疗脑梗死恢复早期肢体运动障碍的临床疗效和作用机制。方法:对29例脑梗死恢复早期肢体运动障碍的患者,给予4周的藏药珍龙醒脑胶囊口服治疗。治疗4周后,观察患者《中风病证候要素评价量表》、Fugl-Meyer运动功能评定量表(Fugl-Meyer Assessment,FMA)和美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分的改变及不良反应发生情况,并在治疗前后对患者进行磁共振扩散张量成像,采用基于纤维束示踪的空间统计方法获取治疗前后各向异性分数值差异的脑区进行分析。结果:治疗后患者的内火、痰湿、血瘀证候的积分较治疗前降低(P<0.05);FMA总分和NIHSS总分较治疗前改善(P<0.05);胼胝体体部、胼胝体压部、胼胝体毯、丘脑后辐射、放射冠、左侧上纵束、左侧外囊、右侧内囊前肢等脑区的各向异性分数值较治疗前升高(P<0.05)。治疗期间,受试者无不良反应发生。结论:珍龙醒脑胶囊治疗脑梗死恢复早期肢体运动障碍的患者,用药4周是有效且安全的。珍龙醒脑胶囊能有效改善脑梗死恢复期患者的肢体运动功能障碍,其作用机制可能与胼胝体、放射冠等脑区受损白质纤维束的修复与重组相关。
基金the 2019 Major Difficult Diseases Clinical Collaboration Capacity Building Project of Traditional Chinese and Western Medicine-cerebral Infarction(No.YW082)。
文摘Vertebrobasilar dolichoectasia(VBD),a rare posterior circulation vascular variant disease,is an important risk factor for many acute cerebrovascular diseases.An insufficient understanding of VBD often leads to misdiagnose.Two cases of VBD that were initially diagnosed as posterior circulation watershed infarction are reported here.Absence of common causes of stroke including hypoperfusion,blood system diseases,carotid and aortic dissection,and eosinophil elevation,the symptoms of the 2 patients met the diagnostic criteria of VBD.Both patients displayed symptoms that were in line with the Traditional Chinese Medicine(TCM)syndrome pattern of"Qi deficiency and blood stasis".Accordingly,they were comprehensively treated with Supplementing Qi and activating blood circulation method.The clinical manifestations of the 2 patients were remarkably improved and no recurrence of watershed infarction was found in a 1-year follow-up.A detailed medical history and laboratory examination are capable of improving diagnostic accuracy of VBD.TCM treatment based on syndrome identification might be a promising candidate for VBD management.
